TIBET PHARMACEUTICALS, INC.
DelistedCIK 1489077fmd_1Q096G4N6HGA3R57Q5A0E64B5KManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2011, 5 periods
Latest annual · FY2010
Millions- Net income
- 13
Latest quarter · Q3 FY2011
Millions- Total revenues
- 9
- Gross profit
- 3
- Operating income
- 2
- Net income
- 2
TIBET PHARMACEUTICALS, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2010 | Change | Source | |
|---|---|---|---|---|
| Net income | $13.1 million | 10-Q/A 2011-08-29 · proof | ||
| Total assets | $26.9 million | 10-Q 2011-11-14 · proof | ||
| Total liabilities | $3.4 million | 10-Q 2011-11-14 · proof | ||
| Cash and cash equivalents | $7.6 million | 10-Q 2011-11-14 · proof |
- What was TIBET PHARMACEUTICALS, INC.'s net income in fiscal 2010?
- TIBET PHARMACEUTICALS, INC. reported net income of $13.1 million for fiscal 2010 (the year ended Dec 31, 2010). Source: the 10-Q/A filed with the SEC on Aug 29, 2011. SEC
- What are TIBET PHARMACEUTICALS, INC.'s total assets?
- As of Dec 31, 2010, TIBET PHARMACEUTICALS, INC. reported total assets of $26.9 million. Source: the 10-Q filed with the SEC on Nov 14, 2011 (restated). SEC
- What are TIBET PHARMACEUTICALS, INC.'s total liabilities?
- As of Dec 31, 2010, TIBET PHARMACEUTICALS, INC. reported total liabilities of $3.4 million. Source: the 10-Q filed with the SEC on Nov 14, 2011. SEC
- What are TIBET PHARMACEUTICALS, INC.'s cash and cash equivalents?
- As of Dec 31, 2010, TIBET PHARMACEUTICALS, INC. reported cash and cash equivalents of $7.6 million. Source: the 10-Q filed with the SEC on Nov 14, 2011 (restated). SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1489077&period_type=annual&limit=5"Information only, not investment advice.